Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Perjeta 2016-2017 U.S. Promotional Report - Research and Markets

Research and Markets
Posted on: 12 Dec 17

The "Perjeta 2016 U.S. Promotional Report" report has been added to Research and Markets' offering.

The 5 Key Questions Addressed by this Report:

  • How many physicians were reached by Perjeta through personal promotion in 2016 and how does this compare to its peer set in the Breast Cancer markets?
  • What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend on each type of activity?
  • How does Genentech's depth of coverage vary within key specialties (e.g., Hematology/Oncology, General Surgery, Medical Oncology, Internal Medicine, and Pathology) and how does this compare to its peers and the overall set of rep-accessible physicians?
  • How often are physicians receiving paid meals for Perjeta throughout the year (e.g., monthly, quarterly, annually)?
  • Who were the most detailed prescribers and top paid speakers for Perjeta in 2016?

Data Sources and Methodology:

  • We leverage company-reported financial transaction data disclosed through CMS Open Payments. This data set captures all transfers of value (e.g., speaking fees, consulting fees, travel, education, and meals) made on behalf of a drug or device manufacturer to a physician. Currently, 42 months of longitudinal data is available - covering payments to more than 900,000 U.S. healthcare professionals.
  • Over 13,100 paid interactions across 4,700 physicians made on behalf of Perjeta were carefully examined to support our analysis. In addition, interaction data from 10 peer products (e.g. Abraxane, Afinitor, Avastin, Fareston, Faslodex, Halaven, Herceptin, Ibrance, Ixempra, and Kadcyla) was leveraged to provide benchmarking and market insights.

For more information about this report visit https://www.researchandmarkets.com/research/nmhdt3/perjeta_20162017?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20171212006240/en/

Business Wire
www.businesswire.com

Last updated on: 12/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.